EMR posts solid Q4 results with stronger margins and upbeat FY26 guidance, driven by Software & Control growth.

Emerson’s Q4 2025 results showed steady growth, with EPS meeting expectations and revenue slightly below estimates.

As a reminder, Q1 2025 adjusted EPS of $1.38 included the benefit of several dynamics such as discretionary cost containment and favorable project closeouts in Control Systems & Software. It's also ...

Emerson (NYSE: EMR) reported it has secured a contract with Lithium Americas to supply its extensive automation portfolio and ...

Robotics companies are at the forefront of innovation, driving efficiency and productivity across industries such as manufacturing, healthcare and logistics. The global robotics market is poised for ...

Learn how CI/CD on cloud (AWS, Snowflake) plus Terraform & Airflow can speed releases, reduce MTTR, and improve reliability ...

In an era where clinical precision, operational efficiency, and patient satisfaction dictate the success of healthcare ...

Detailed price information for Emerson Electric Company (EMR-N) from The Globe and Mail including charting and trades.

Despite widespread digital transformation in healthcare, faxing remains a deeply entrenched communication tool. Over ...

Raintree, the leading provider of AI-powered software solutions for rehabilitation and physical therapy organizations, today announced the release of a groundbreaking new whitepaper in partnership ...

Emerson (NYSE: EMR) today announced it has been selected by Lithium Americas Corp. to provide its comprehensive automation ...

Healthcare technology company io Health announced on Oct. 7 that it raised $2 million in seed funding to expand an artificial intelligence platform showing results in clinician retention and ...